Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Cancer Type/Condition:  Skin cancer, neuroendocrine carcinoma (Merkel cell)
Stage/Subtype:  stage III neuroendocrine carcinoma of the skin
Country:  U.S.A.
Trial Type:  Treatment
Results 1-2 of 2 for your search:
Start Over
A Study to Investigate the Safety and Efficacy of Nivolumab, and Nivolumab in Combination With Ipilimumab, in Virus-associated Tumors (CheckMate358)
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: CA209-358, NCI-2015-01356, 2015-000230-29, NCT02488759
Pembrolizumab in Treating Patients with Advanced Merkel Cell Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CITN-09, NCI-2014-00848, MK-3475, NCT02267603
Start Over